Potentiators and bolus intravenous furosemide [11]

Lancet

Volumn 358, Issue 9290, 2001, Pages 1373-1374

  Cook, David J ^a   Tudball, Coral F ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DIURETIC AGENT; FUROSEMIDE; LOOP DIURETIC AGENT; MAGNESIUM; PENTETIC ACID; RADIOISOTOPE;

HEARING IMPAIRMENT; HUMAN; HYPOALBUMINEMIA; INJECTION; KIDNEY DISEASE; LETTER; NEPHROTOXICITY; NUCLEAR MEDICINE; OBSTRUCTIVE UROPATHY; OTOTOXICITY; PREMATURITY; PRIORITY JOURNAL; RENOGRAPHY; TINNITUS; URETER DILATATION;

EID: 0035922596     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(01)06443-1     Document Type: Letter

References (4)

1. Einfluss hoher furosemiddosen auf die gehofunktion bei uramie
2. Consensus on diuresis renography for investigating the dilated upper urinary tract: Radionuclides in Nephrourology Group Consensus Committee on Diuresis Renography
3. Is the direct intravenous injection of furosemide during MAG3 diuresis renography safe?
4. Risk factors of sensorineural hearing loss in preterm infants